Blood Grouping Reagents [3491841]
A Tender Notice
by PROCUREMENT AND LOGISTICS SERVICE
- Source
- Find a Tender
- Type
- Contract (Goods)
- Duration
- 7 year
- Value
- £46M-£1M
- Sector
- HEALTH
- Published
- 24 Nov 2021
- Delivery
- To 30 Nov 2028 (est.)
- Deadline
- 06 Jan 2022 15:00
Concepts
Location
3 buyers
- Procurement & Logistics Service Belfast
- Belfast Health & Social Care Trust Belfast
- NI Blood Transfusion Service Belfast
Description
Blood Grouping Reagents [3491841]
Lot Division
| 1 | 1.1 Anti-A
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 2 | 1.2 Anti-B
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 3 | 1.3 Anti-A,B
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 4 | 2.1 IgM Anti-D
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents Award Criteria
| ||
| 5 | 2.2 Blend Anti-D
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 6 | 3.1 Anti-C
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 7 | 3.2 Anti-E
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 8 | 3.3 Anti-c
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 9 | 3.4 Anti-e
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 10 | 4.1 Anti-JKa
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 11 | 4.2 Anti-JKb
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 12 | 5.1 Anti-M
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 13 | 5.2 Anti-N
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 14 | 6.1 Anti-S
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 15 | 6.2 Anti-s
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 16 | 7.1 Anti-Lea
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 17 | 7.2 Anti-Leb
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 18 | 8.1 Anti-Fya
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 19 | 8.2 Anti-Fyb (must be capable of detecting Fyx)
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 20 | 9. Anti-A1
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 21 | 10. Anti-Cw
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 22 | 11. Anti-K
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 23 | 12. Anti-k
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 24 | 13. Anti-Kpa
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 25 | 14. Anti-Kpb
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 26 | 15. Anti-P1
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 27 | 16. Anti-Lua
| ||
| 28 | 17. Anti-Lub
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 29 | 18. Anti-Coa
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 30 | 19. Anti-Cob
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 31 | 20. Anti-H
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 32 | 21. Anti-Wra
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 33 | 22. Anti-Vw
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 34 | 23. Coombs Control
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 35 | 24. Monoclonal Control
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 36 | 25. AB Serum
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 37 | 26. PeG
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 38 | 27. Anti-IgG
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 39 | 28. Anti-C3d
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents | ||
| 40 | 29. Poly AHG
Blood Grouping Reagents [3491841] Additional information: The estimated value stated is the highest value in a range of 490000 to 1155000 GBP which has been calculated on the basis of a 7 year contract with an option to extend for any period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award Criteria, Scoring and Weightings are detailed within the tender documents |
CPV Codes
- 33696100 - Blood-grouping reagents
- 33000000 - Medical equipments, pharmaceuticals and personal care products
- 33600000 - Pharmaceutical products
Indicators
- This is a recurring contract.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-02f992
- FTS 029219-2021